Filing Details

Accession Number:
0001571049-17-002511
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-16 19:51:41
Reporting Period:
2017-02-27
Filing Date:
2017-03-16
Accepted Time:
2017-03-16 19:51:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069899 Phibro Animal Health Corp PAHC Pharmaceutical Preparations (2834) 131840497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603461 A Daniel Welch 300 Frank W. Burr Blvd., Ste 21
Teaneck NJ 07666-6712
Sr Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2017-02-27 3,100 $11.83 3,100 No 4 M Direct
Class A Common Stock Acquisiton 2017-02-27 1,900 $11.83 1,900 No 4 M Direct
Class A Common Stock Disposition 2017-02-27 5,000 $28.30 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Option to purchase Class A Common Stock Disposition 2017-02-27 3,100 $0.00 3,100 $11.83
Class A Common Stock Option to purchase Class A Common Stock Disposition 2017-02-27 1,900 $0.00 1,900 $11.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-03-01 2019-02-28 No 4 M Direct
9,150 2013-03-01 2019-02-28 No 4 M Direct
Footnotes
  1. Reflects conversions of options with an exercisable date of March 1, 2012.
  2. Reflects conversions of options with an exercisable date of March 1, 2013.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.95 to $28.75, inclusive.
  5. The Date Exercisable for the securities included on this line was incorrectly reported in the Form 4 for Mr. Welch filed on February 16, 2017. The information in this line reflects the correct Date Exercisable for the Options to purchase Class A Common Stock.
  6. Report is being submitted late due to a technical error.